Patent · US Active

Hepcidin inhibitors for regulating iron homeostasis

US9234903B2 · kind B2 · utility

0Cited by

7References

1Claims

0Family size

Assignee

INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR

Inventors

Gael Nicolas · Paris, FR
Sophie Vaulont · Paris, FR
Axel Kahn · Paris, FR

Key dates

Filing date	Nov 21, 2006
Grant date	Jan 12, 2016
Priority date	—
Expiry date	Nov 15, 2029

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/90
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention concerns the use of hepcidin for the diagnosis and therapy of disorders of iron homeostasis. Hepcidin can be used in the treatment of disorders resulting from iron overload while inhibitors of hepcidin can be used in the treatment of anemia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.